EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Construction of a GCSCs-Related Prognostic Risk Model Based on Transcriptomic Data

Xin Hu, Shiqi Fan, Naiqiang Liu iD, Muchen Fan iD, Yewen Wu, Guang Shi, Yangguang Su, Lei Liu, Xiujie Chen iD

International Journal of Molecular Sciences · 28.10.2026 · 27 (21) · 9669

DOI: 10.3390/ijms27219669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.10.2026. Verfasst von Xin Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neoplastic Stem Cells, Transcriptome. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric Cancer Stem Cells (GCSCs) contribute to tumor progression and treatment resistance, but their heterogeneity and tumor microenvironment interactions remain unclear. We analyzed GSE163558 single-cell RNA-sequencing data from 10 gastric cancer samples and integrated GCSC-related genes with The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD) training cohort (n = 448) and two independent external validation cohorts, GSE62254 (n = 300) and GSE84437 (n = 483), to construct and validate a six-gene prognostic risk model. Cell–cell communication, metabolic activity, immune infiltration, immunotherapy response, and drug sensitivity were evaluated. Nine cell populations, including a putative GCSC population, were identified. GCSCs showed higher inferred oxidative phosphorylation activity and extensive predicted interactions with tumor-associated cells. The model stratified patients into distinct prognostic groups. High-risk tumors exhibited enrichment of progression-related pathways, including epithelial–mesenchymal transition, and distinct immune features. In PRJEB25780 (n = 78), higher risk scores were associated with immunotherapy non-response, whereas an exploratory analysis of GSE91061 (n = 49) showed a similar trend. The model may support prognostic stratification and provide insights into potential associations with therapeutic response, pending prospective validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsNeoplastic Stem CellsTranscriptomeHumansPrognosisGene Expression Regulation, NeoplasticTumor MicroenvironmentBiomarkers, TumorGene Expression ProfilingEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

gastric cancergastric cancer stem cellsimmunotherapyprognostic risk modelsingle-cell RNA sequencingtumor immune microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.

ORCID-Profile: Naiqiang Liu, Muchen Fan, Xiujie Chen

Zitieren

APA

Hu, X., Fan, S., Liu, N., Fan, M., Wu, Y., Shi, G., Su, Y., Liu, L., & Chen, X. (2026). Construction of a GCSCs-Related Prognostic Risk Model Based on Transcriptomic Data. International Journal of Molecular Sciences, 27(21), 9669. https://doi.org/10.3390/ijms27219669

Vancouver

Hu X, Fan S, Liu N, Fan M, Wu Y, Shi G, et al. Construction of a GCSCs-Related Prognostic Risk Model Based on Transcriptomic Data. International Journal of Molecular Sciences. 2026;27(21):9669. doi:10.3390/ijms27219669

BibTeX
@article{Hu2026,
  author = {Hu, Xin and Fan, Shiqi and Liu, Naiqiang and Fan, Muchen and Wu, Yewen and Shi, Guang and Su, Yangguang and Liu, Lei and Chen, Xiujie},
  title = {Construction of a GCSCs-Related Prognostic Risk Model Based on Transcriptomic Data},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {9669},
  doi = {10.3390/ijms27219669}
}
Kostenlos starten →